Table of contents
Expand All Topics
Tardive dyskinesia
Guidelines
Key sources
The following summarized guidelines for the management of tardive dyskinesia are prepared by our editorial team based on guidelines from the American Academy of Neurology (AAN 2013).
1
Medical management
Switching to atypical antipsychotics: as per AAN 2013 guidelines, insufficient evidence to support or refute treatment of tardive syndromes by withdrawing causative agents or switching from typical to atypical dopamine receptor blocking agent.
I
More topics in this section
Clonazepam
Risperidone
Amantadine and tetrabenazine
Agents with no evidence for efficacy